Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
US8829198B2 · kind B2 · utility
0Cited by
41References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2008 |
| Grant date | Sep 9, 2014 |
| Priority date | — |
| Expiry date | Mar 15, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of β-amyloid diseases, such as observed in Alzheimer's disease, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.